Published in Medical Letter on the CDC and FDA, July 9th, 2006
The results of the 120 day safety update were consistent with prior data from the Neurodex IEED trials and were submitted to the FDA. Additional results from this study will continue...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.